Industry Voice

INDUSTRY

In conversation with Gilead Canada’s Christophe Griolet

Industry Voice sat down with Christophe Griolet, General Manager of Gilead Sciences Canada, to discuss how he applies global learnings in a local context, his commitment to health equity, and the incredible promise of personalized medicine.

INDUSTRY

In conversation with Amylyx Canada’s Chris Aiello

Industry Voice connected with Chris Aiello, General Manager at Amylyx Canada, to learn about his personal connection to rare disease, what he believes makes the ALS community unique, and why he and his team never take “no” for an answer.

INDUSTRY

In conversation with Taiho Canada’s Ross Glover

Industry Voice connected with Ross Glover, General Manager at Taiho Canada, to understand how he defines success when developing and marketing novel cancer therapies and to discuss why and how a biotech’s culture plays a vital role in improving patient outcomes.

INDUSTRY

In conversation with Ultragenyx Canada’s Monty Keast

Industry Voice connected with Ultragenyx Canada’s Monty Keast to explore why he’s passionate about bringing novel therapies to underserved patient communities and why rare diseases must be treated differently than other, more common conditions.

INDUSTRY

In conversation with BeiGene Canada’s Peter Brenders

Industry Voice sat down with Peter Brenders, General Manager of BeiGene Canada, to discuss why he’s passionate about developing novel therapies for Canada’s blood cancer communities.